NCT05711420 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Akin, A
, Ugur, E., &; Akin, Ü. (2015). Derse Ilgi Ölçeginin Türkçe Formu: Geçerlik ve güvenirlik çalismasi. K. U. Kastamonu Egitim Dergisi 23 (4), 1467-1476.
ÇETIN, S
, & ÇETIN, F. (2019). Ögrenmeye yönelik tutum ölçegi (ÖYTÖ) gelistirme çalismasi. Türk Egitim Bilimleri Dergisi, 17(1), 140-157.
Dinçer, S
, & Doganay, A. (2016). Ögretim materyali'ne iliskin motivasyon ölçegi (ÖMMÖ) Türkçe uyarlama çalismasi. Ilkögretim Online, 15(4).
Keller, J
M. (2010). Motivational design for learning and performance: The ARCS Model approach. New York, NY: Springer.
Mazer, J
, P. (2013). Validity of the Student Interest and Engagement Scales: Associations with student learning outcomes. Communication Studies, 64, 125-140.

Comparison of the Effects of the Education Given to Nursing Students by Gamification Method and Flipped Learning Method on the Level of Participation, Attitude, Interest and Motivation

Details for clinical trial NCT05711420

Clinical trial NCT05711420 - References